Mutations in the regulatory subunit of soluble phosphofructokinase from yeast

Mutant alleles of the gene PFK2 have been obtained that alter the sensitivity to ATP inhibition of the soluble yeast phosphofructokinase. One of the alleles makes the enzyme sensitive to micromolar concentrations of ATP. Intragenic revertants of PFK2 mutants confirm that the PFK2 gene determines not only the regulatory properties of the soluble enzyme but also the catalytic activity of particulate phosphofructokinase

Evaluation of immunomodulatory activity of Suvarnamalini vasant,^®a generic Ayurvedic herbomineral formulation

115-116Suvamamalini vasant-a generic Ayurvedic herbomineral preparation was studied for its immunomodulatory activity by 1) evaluating it's effect on phagocytic function of polymorphonuclear white blood cells of rats and 2) it's effect in E. coli-induced peritonitis in albino mice. Pretreatment of rats with Suvarnamalini vasant improved the phagocytic function of polymorphonuclear white blood cells and also protected mice against E.coli-induced peritonitis. The results indicate the potential of Suvarnamalini vasant as an immunomodulator

Multiple genes control particulate phosphofructokinase of yeast

Mutants of Saccharomyces cerevisiae lacking the particulate phosphofructokinase define at least four unlinked genes, PFK2, PFK3, PFK4 and PFK5. A structural role of PFK2 is indicated. Mutations in the other three have pleiotropic effects